Adjuvant Oral Decitabine and Tetrahydrouridine With or Without Celecoxib in People Undergoing Pulmonary Metastasectomy
Conditions: Neoplasm Metastasis; Sarcoma; Neoplasms, Germ Cell and Embryonal; Melanoma Interventions: Drug: decitabine (DAC); Drug: Tetrahydrouridine (THU); Drug: Celecoxib Sponsor: National Cancer Institute (NCI) Recruiting - verified July 2016
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer & Oncology | Celebrex | Embryonal Carcinoma | Melanoma | Oral Cancer | Research | Sarcomas | Skin Cancer